Published in Cancer Weekly, April 6th, 2004
The presentation, entitled "Motexafin Gadolinium in Hematologic Malignancies," outlined early data from an ongoing study evaluating Xcytrin for the treatment of recurrent CLL.
Eleven patients, each who had failed several prior treatment regimens for the disease, were given Xcytrin daily for 5...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.